Richard A. Miller - Jun 24, 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
President and CEO, Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Stock symbol
CRVS
Transactions as of
Jun 24, 2022
Transactions value $
$10,135
Form type
4
Date filed
6/28/2022, 07:15 PM
Previous filing
Jun 10, 2022
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $5.15K +5K +0.37% $1.03 1.34M Jun 24, 2022 By Trust F1
transaction CRVS Common Stock Purchase $4.98K +5K +0.37% $1.00 1.35M Jun 27, 2022 By Trust F1
holding CRVS Common Stock 35.7K Jun 24, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.